Company Filing History:
1 out of 832,880 Years Active: 1986
Title: The Innovations of Michel Chretien: Unveiling the Glycopeptide Pioneering Research
Introduction
Michel Chretien, a notable inventor from St. Lambert, Quebec, Canada, has made significant contributions to the field of biochemistry. With a keen focus on the human pro-opiomelanocortin, his innovative work has resulted in one key patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Chretien holds a patent for the "N-terminal fragment of human pro-opiomelanocortin and process therefor." This patent highlights the N-terminal fragment, which is a glycopeptide composed of 76 amino acid residues. The invention details a process for preparing this fragment from human pituitary glands. This glycopeptide is pivotal in various applications, including potentiating the effects of ACTH on steroidogenesis and stimulating the production of aldosterone. It also serves as a valuable diagnostic tool and reagent for detecting its presence in biological fluids and tissues through immunochemical methods.
Career Highlights
Throughout his career, Michel Chretien has been recognized for his innovative approach to research. His work has significantly contributed to the understanding of hormone regulation and its implications for various medical conditions. Chretien’s dedication to advancing biochemistry has established him as a prominent figure in the field, influencing both academic and clinical research.
Collaborations
In his journey, Chretien has collaborated with esteemed colleagues, notably Nabil G Seidah, whose partnership has enriched research efforts in the realm of glycoproteins and their clinical relevance. Together, they have made strides in advancing the understanding of pro-opiomelanocortin and its fragments.
Conclusion
Michel Chretien's contributions to science, especially through his patent on the N-terminal fragment of human pro-opiomelanocortin, reflect a commitment to innovative research that holds promise for various diagnostic and therapeutic applications. His work not only enhances the field of biochemistry but also paves the way for future discoveries that could transform patient care.